A study of integrin a3ß5 on the molecular mechanism of acute type A aortic dissection based on single cell sequencing technology

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048327

Enrollment

Unknown

Registered

2021-07-05

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute type A aortic dissection

Interventions

Aortic dissection group:None

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Patients with acute chest and back pain onset, aortic dissection, aortic intermural hematoma or aortic ulcer confirmed by aortic CTA or cardiac ultrasound; Or patients with other chief complaints, aortic dissection confirmed by aortic CTA; 2.There is no limitation on gender; 3.Aged 18 to 90 years.

Exclusion criteria

Exclusion criteria: 1.Aortic aneurysm not ruptured; 2.Patients with advanced malignant tumors; 3.Recent history of obvious trauma such as fracture; 4.Patients who have experienced electric defibrillation, electric cardioversion and chest compressions during the course of the disease; 5.Pregnancy period, perinatal period and patients who do not want to participate in this study.

Design outcomes

Primary

Measure	Time frame
aorta;Discharge or death;	—

Countries

China

Contacts

Public ContactGu Guorong

Zhongshan Hospital, Fudan University

gu.guorong@zs-hospital.sh.cn+86 13681972756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026